A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The main purpose of this study is to assess the safety and efficacy of peresolimab in adult participants with moderately-to-severely active rheumatoid arthritis.
Epistemonikos ID: f16d53e5e209d13090b949675a2be61e2ea92e59
First added on: May 13, 2024